DaVita (NYSE:DVA) Price Target Raised to $228.00

DaVita (NYSE:DVA) had its target price lifted by TD Cowen from $220.00 to $228.00 in a research note published on Monday,Benzinga reports. TD Cowen currently has a buy rating on the stock.

DVA has been the subject of a number of other research reports. Raymond James Financial set a $220.00 target price on DaVita in a research note on Friday, August 7th. Zacks Research downgraded DaVita from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. UBS Group increased their price objective on DaVita from $270.00 to $287.00 and gave the company a “buy” rating in a report on Monday. Truist Financial reduced their price objective on DaVita from $250.00 to $215.00 and set a “hold” rating for the company in a research note on Friday, August 7th. Finally, Weiss Ratings raised DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, October 9th. Four investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $235.86.

DaVita Trading Up 5.7%

NYSE:DVA opened at $192.59 on Monday. The company has a market cap of $12.11 billion, a PE ratio of 14.18, a P/E/G ratio of 0.46 and a beta of 0.87. DaVita has a twelve month low of $101.00 and a twelve month high of $247.49. The company’s 50 day moving average is $181.98 and its two-hundred day moving average is $177.72.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, October 29th. The company reported $3.82 EPS for the quarter, topping the consensus estimate of $3.57 by $0.25. The business had revenue of $3.58 billion during the quarter, compared to the consensus estimate of $3.52 billion. DaVita had a net margin of 6.49% and a negative return on equity of 225.93%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.51 earnings per share. As a group, analysts expect that DaVita will post 14.66 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of DVA. CoreCap Advisors LLC grew its stake in DaVita by 161.7% in the 3rd quarter. CoreCap Advisors LLC now owns 157 shares of the company’s stock valued at $27,000 after acquiring an additional 97 shares during the period. Provenance Wealth Advisors LLC purchased a new stake in DaVita in the 3rd quarter worth $30,000. Root Financial Partners LLC raised its position in DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after acquiring an additional 105 shares during the period. Compass Financial Management LLC acquired a new position in DaVita during the second quarter worth $72,000. Finally, NewEdge Advisors LLC lifted its holdings in DaVita by 66.4% during the second quarter. NewEdge Advisors LLC now owns 361 shares of the company’s stock valued at $80,000 after purchasing an additional 144 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc (NYSE: DVA) is a health care services company focused on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with chronic kidney failure, including in-center hemodialysis, home dialysis and related clinical support services.

DaVita also offers integrated kidney care programs intended to support patients across the stages of chronic kidney disease. Its services may include care coordination, disease management, education, transplant support and other services designed to improve clinical outcomes and help manage the needs of patients with complex kidney conditions.

The company operates a network of dialysis centers and related facilities in the United States and serves patients in select international markets.